Contact

Top venture capital most active in E-Health


, , ,
Integral service around a transaction
BY : Diego GutiérrezAugust Tue, 2016
We have recently learned that Apple has bought Glimpse, a personal health data platform with which users or patients can collect, personalise and share an image of their health data. This company was founded in 2012 and in 2014 received an investment round of 800,000$ in which GV, Matt Monahan and Sherpa Capital participated and which was necessary to give it the necessary liquidity to be able to develop its product.
Do you think your company would also need a venture capital is? Here are the 3 most active investors since 2014.

List of most active investors since 2014

venture capital e-health

 

Rock Health

 Founded in 2010, it is a venture capital firm focused on early-stage digital health investments.

Investments are typically in the region of 250K, as well as providing strategic and operational support and access to partners, medical academies and medical centres.

Among its latest investments is Elemental Machine, a company that helps accelerate scientific discovery through cloud-based software and machine learning. The company enables the collection and visualisation of critical data about the physical environment that can influence its experiments.

Although this venture capital is mainly focused on early stage companies, it has also participated in more advanced rounds such as $48M closed in 2015 in the company Omada Healtha company that develops web technology for the health sector.

 

Khosla Ventures

 Unlike Rock Health, Khosla Ventures is not only focused on e-health investments. Khosla invests in technology companies in different fields: environment, ICT, health, mobility...

One niche in which Khosla has been very active has been in the internet of things applied to healthcare. Among the companies in this area in which Khosla has invested are: AstroPrint,Biobots,BioFab, CreoPop, Grom, MarketBot, Pinshape.

In addition, Khosla has previously invested in Spain in other sectors such as mobility.

Qualcomm Ventures

 Founded in 2000, it has made more than 232 investments in technology companies in various sectors.

Last year Novartis launched a fund together with Qualcomm Ventures, to drive new technologies in the digital domain with the potential to change medical practice and improve patients' lives.

Among the companies in which Qualcomm has invested are: Common Sensing, a device to help diabetics manage their disease, and Welltok, which offers users personalised information and incentives to improve their health and habits.

Other posts that may interest you

Investment activity "IOT wearables" for clinical efficiency

Innovation in Iot applied to health

Artificial intelligence in the E-health sector

 

The M&A Professionals

Meet our services

CONTACT US

MEET
OUR
METODOLOGY

Do you want to be up to date?

SUSCRIBE OUR NEWSLETTER

Our diferentiation

Market Research Technology
Our team of market analysis specialists is continuously analyzing the investments of the most active markets in the industry in order to unceasingly contribute ideas of the current market situation and identify the most relevant trends for senior management. We integrate the most relevant sources of information which allows us to discover the most interesting companies for venture capital and similarly helps us to identify the investors with the highest probability of involvement in an M&A process to ensure the success of our sell-side operations.

The reports and deductions of our advisors provide a broad view of the sector, both geographically and from the complementary or adjacent markets perspective.
Technology Data Analytics
for M&A
Advanced data anlytics is a weapon". Intelfin is an artificial intelligence tool we use for investing and creating value in SMEs through competitive analytics and the enterprise environment.

IntelFin consists of a cognitive system, which, through the application of advanced analytical technologies, facilitates the automation of investment and financing decisions in the field of non-listed companies and especially SMEs in high-growth sectors.

The information related to these companies is characterized by their lack of transparency and heterogeneity; thus, it is necessary to develop an advanced analysis which is as much predictive as prescriptive and is developed in a natural language custom, suitable to obtain greater clarity and knowledge of the investment scope.

The IntelFin system focuses especially on analyzing the variables that define and influence the competitive environment of a sector and the positioning of a company, analyzing their influence on future value creation. Therefore, IntelFin supports strategic decision-making to senior management by resolving questions such as:

¿What are my competitors' priorities, strategies and expansion plans? Who's my competition? Which competitor is most likely to grow at a higher rate?
Which areas of activity/business models will receive the most investment? Which sectors are most attractive to investors?
Which companies are going to experience the most growth in the near future? Which companies are most likely to receive investment or be acquired?
Training Methodology
We have developed training programs in an innovative set-up which guarantees our teams the acquisition of technical competences both in the field of corporate finance and in the field of psychology, that is much needed when it comes to negotiation processes.

We have a culture of continuous improvement of our processes, closely related to the use of information systems that allow the enhancement of internal communication between our teams, as well as external communication with our customers. Hence, we extend best practices identified internally in an efficient and rapid manner among our members.

Are you one of those who prefer to be well informed when making decisions?

M&A NEWS
INDUSTRIAL REPORTS
crossmenu